Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity

Area of Science:

• Dermatology and Oral Medicine
• Immunobullous Disorders
• Subepithelial Vesiculobullous Diseases

Background:

• Oral manifestations in dermatoses are often linked to mucous membrane pemphigoid or lichen planus.
• Mucous membrane pemphigoid, a subepithelial vesiculobullous disorder, primarily affects middle-aged women.
• Previously considered a single entity, it's now recognized as part of a spectrum of immune-mediated subepithelial blistering diseases.

Purpose of the Study:

• To review the European Symposium on Mucous Membrane Pemphigoid held in Turin, 1997.
• To highlight the diagnostic challenges and management strategies for immune-mediated subepithelial blistering diseases.
• To discuss the clinical presentation and therapeutic approaches for oral involvement in mucous membrane pemphigoid.

Main Methods:

• Review of findings from the 1997 European Symposium on Mucous Membrane Pemphigoid.
• Emphasis on the necessity of a thorough patient history and clinical examination.
• Requirement for biopsy with immunostaining, potentially supplemented by other investigations for accurate diagnosis.

Main Results:

• Recognition of diverse subepithelial vesiculobullous disorders presenting similarly to mucous membrane pemphigoid.
• Identification of antibodies targeting hemidesmosomal components or epithelial basement membrane.
• Common oral presentation includes desquamative gingivitis, vesicles, and erosions; other stratified epithelia can also be involved.

Conclusions:

• Diagnosis of immune-mediated subepithelial blistering diseases cannot rely on clinical presentation alone.
• Accurate diagnosis requires a combination of clinical evaluation, patient history, and laboratory investigations like immunostaining.
• Effective management of oral lesions in mucous membrane pemphigoid typically involves immunomodulatory and immunosuppressive therapies.